OBIZUR

STN: BL 125512
Proper Name: Antihemophilic Factor (Recombinant), Porcine Sequence
Tradename: OBIZUR
Manufacturer: Baxter Healthcare Corporation
Indication:

Treatment and control of bleeding episodes in adults with acquired hemophilia A.

Product Information

Supporting Documents

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

OBIZUR

Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.